Summary
The experiments proove the hemostatic effect of both Premarin and Styptanon. Premarin seems to be more effective than Styptanon in the same dosage.
Zusammenfassung
Sowohl Premarin als auch Styptanon besitzen blutstillende Eigenschaften. Doch scheint bei gleicher Dosierung das Premarin wirksamer zu sein als das Styptanon.
Similar content being viewed by others
Literatur
Bell, G. H., S. Lazarus, andH. N. Nunro: Capillary fragility; Critical analysis Lancet1940 II, 155.
Borchgrevick, G. F., R. Anderson, J. Hall, K. Hatteland, andUrsin-Holm: Premarin as a hemostatic agent: failure to demonstrate any laboratory or clinical effect. Brit. med. J.1960, 1945.
Brewer, J. I.: Rhythmic changes in skin capillaries and their relation to menstruation. Amer. J. Obstet. Gynec.36, 597 (1938).
Cooner, W. H., andH. M. Burros: Clinical evulation of effect of “Premarin” on bleeding during and following prostatic surgery. J. Urol. (Baltimore)83, 64 (1960).
Firat, D., andL. Stutzmann: Blood thrombocyt levels after administration of equine estrogens. Prov. Soc. exp. Biol. (N.Y.)103, 474 (1964).
Goldberg, J. L.: Conjugated estrogens in the preventation of secondary hyphema after ocular trauma. Arch. Ophthal.63, 1001 (1960).
Heinberg, G. J.: Treatment of hemorrhage in non hemophilic patients with an estrogenic substance. Arch. Otolaryng.24, 758 (1936).
Houtsmüller, K. H.: Klinische Erfahrungen mit Östriolsuccinat und Nandrolondecanoat bei Gefäßwandstörungen. Int. Gespräch über Angiologie. Darmstadt 1962.
Jacobson, P.: Spontaneous hemorrhage: A clinical entity with special reference to the bleeding state, pathology and hemostasis. Virginia med. Mth.85, 548 (1956).
— Hormonal managment of spontaneous hemorrhage. Virginia med. Mth.84, 396 (1957).
Jacobson, P.: Bleeding Peptic Ulcer. A form of spontaneous hemorrhage. Virginia med. Mth.88, I (1961).
Jacobson, P (Correspondence): “Premarin” as a Hemostatic agent. Brit. med. J.1961 I, 360.
—: Intimal hemorrhage a form of spontaneous hemorrhage, it's relation to atherosclerosis and coronary occlusion. Virginia med. Mth.88, 349 (1961).
Johnson, J. K. F., andW. H. Seeger: Changes in plasma prothrombin, acglobulin and antithrombin concentration follogwing intravenous administration of estrogens. Proc. Soc. exp. Biol. (N.Y.)94, 92 (1957).
—— Intravenous estrogens and certain, factors in blood coagulation. Clin. Med.6, 637 (1959).
Kaye, B., J. L. Graziano, andB. E. Reaney: New adjunctive therapy in purpura in the female. Amer. J. Obstet. Gynec.17, 149 (1961).
Lewis, E. I.: Control of oculare hemorrhage with intravenous conjugated estrogenic hormones. Eye, Ear, Nose Thr. Monthly37, 393 (1958).
— Premarin in intraocular surgery: further studies. Eye, Ear, Nose Thr. Monthly38, 215 (1959).
Ludwig, K. H.: Zur Behandlung diabetischer Retinopathien mit konjugierten Östrogenen. Klin. Mbl. Augenheilk.150, 713, H H (1961).
Menger, H. C.: Estrogen given parenterally to control epistaxis and hemorrhage after adenoidectomy. J. Amer. med. Ass.159, 546 (1965).
Poliwoda, H.: Treatment of thrombocytopaemic haemorrhage with oestriol succinate. Nature (Lond.)191, 400 (1961).
Poliwoda, H. Die Beeinflussung thrombocytopenischer Blutungen mittels Östriolsuccinat. Fol. haemat., N. F.6, 1, (1961).
Roberts, H. J.: Control of bleeding after dentalextraction during anticoagulant-therapy with particular reference of estrogenic prophylaxis. J. Amer. med. Ass.175, 962 (1961).
— Oral and intravenous estrogens in the treatment and prevention of bleeding associated with longterm anticoagulanttherapy. J. Amer. Geriat. Soc.9, 1884 (1961).
— Treatment of diabetic retinopathy with estrogens. J. Amer. Geriat. Soc.9, 655 (1961).
Rona, G.: The role of vascular-mucopoly-saccarides in the hemostatic action of estrogens.
Salvator, C. A.: Capillary fragility and menstruation. Surg. Gynec. Obstet.95, 13 (1952).
Scherstein, B.: Remarcs about hemostatics with special referencis of their clinical use. Suom. Lääk-L.13, 855 (1958).
Schiff, M., andH. F. Burn: The effect of intravenous estrogens on ground-substance. Arch. Otolaryng.73, 43 (1961).
—— The effect of estrogens on mastcells and enzymes in connective tissue metabolism in humans. Laryngoscope (St. Louis)71, 765 (1961).
Silva, E. B. de: Treatment of hemorrhage in hemophiliacs and non-hemophiliacs with theelin in oil; preliminary report. Illinois med. J.69, 81 (1936).
Stefanini, M.: The role of intravascular factors in the hemostasis produced by estrogens. Estrogens and Hemostasis. New York: Excerpta Medica Foundation 1961.
Swan, J.: Estrogens in cataract surgery. Amer. J. Ophthal.55, 1142–1153 (1963).
Tey, A.: Fragilidade capilar normal humana. Cit. bySalvatore.
Ueland, K., andJ. T. Parer: Estrogens and cardiovascular system. Amer. J. Obstet. Gynec.96, 3 (1966).
Villadolid, L. S., et al.: Die Wirkung von konjugierten Östrogenen und Östriol succinat auf die Fibrinolyse. Acta Medica Phil. 1965, 82.
Vogt, E.: Theory of so-called endothelium symptom. Dtsch. med. Wschr.48, 1007 (1922).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Avedikian, H. Oestrogene in der Augenheilkunde. Albrecht von Graefes Arch. Klin. Ophthalmol. 175, 174–180 (1968). https://doi.org/10.1007/BF02385062
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02385062